Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Laezza

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Addiction Biology|May 28, 2019
Novel role for cannabidiol in circadian clock functionMaurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
British Journal of Pharmacology|February 28, 2006
Cannabinoids and cancer: pros and cons of an antitumour strategyMaurizio Bifulco, Chiara Laezza, Simona Pisanti, et al.
FEBS Letters|October 24, 2006
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cellsChiara Laezza, Simona Pisanti, Elvira Crescenzi, et al.
Oncology Reports|March 8, 2007
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review)Maurizio Bifulco, Chiara Laezza, Patrizia Gazzerro, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulinMaurizio Bifulco, Chiara Laezza, Stefania Stingo, et al.
Endocrine-Related Cancer|May 30, 2008
Endocannabinoids in endocrine and related tumoursMaurizio Bifulco, Anna Maria Malfitano, Simona Pisanti, et al.
Vitamins and Hormones|August 4, 2009
Cannabinoid receptor CB1 antagonists state of the art and challengesMaurizio Bifulco, Antonietta Santoro, Chiara Laezza, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cellsChiara Laezza, Alba d'Alessandro, Anna Maria Malfitano, et al.
Endocrine-Related Cancer|August 5, 2008
The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathwayChiara Laezza, Simona Pisanti, Anna Maria Malfitano, et al.
International Journal of Molecular Sciences|April 30, 2021
Molecular Mechanism of Cannabinoids in Cancer ProgressionCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Addiction Biology|May 28, 2019
Novel role for cannabidiol in circadian clock functionMaurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
British Journal of Pharmacology|February 28, 2006
Cannabinoids and cancer: pros and cons of an antitumour strategyMaurizio Bifulco, Chiara Laezza, Simona Pisanti, et al.
FEBS Letters|October 24, 2006
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cellsChiara Laezza, Simona Pisanti, Elvira Crescenzi, et al.
Oncology Reports|March 8, 2007
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review)Maurizio Bifulco, Chiara Laezza, Patrizia Gazzerro, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulinMaurizio Bifulco, Chiara Laezza, Stefania Stingo, et al.
Endocrine-Related Cancer|May 30, 2008
Endocannabinoids in endocrine and related tumoursMaurizio Bifulco, Anna Maria Malfitano, Simona Pisanti, et al.
Vitamins and Hormones|August 4, 2009
Cannabinoid receptor CB1 antagonists state of the art and challengesMaurizio Bifulco, Antonietta Santoro, Chiara Laezza, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cellsChiara Laezza, Alba d'Alessandro, Anna Maria Malfitano, et al.
Endocrine-Related Cancer|August 5, 2008
The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathwayChiara Laezza, Simona Pisanti, Anna Maria Malfitano, et al.
International Journal of Molecular Sciences|April 30, 2021
Molecular Mechanism of Cannabinoids in Cancer ProgressionCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Pageof 10